Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)

Study ID: NCT06861790
Start Date: 2025-12
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

tVNS

Complete Vagotomy

Anterior Vagotomy

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders

Study ID: NCT06652802
Start Date: 2025-12-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

74

Intervention / Treatment

Nurse-Conducted Brief Intervention (NCBI). supplemented with mobile based application.

Nurse-Conducted Brief Intervention (NCBI)

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

18F-mFBG Cardiac Uptake With Lewy Body Dementia

Study ID: NCT07176286
Start Date: 2025-11-30
End Date: 2026-07-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

18F-MFBG

Sponsor

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)

Source: clinicaltrials.gov

Share:
Add to list

Validity of Parametric MRI Using VIRADS

Study ID: NCT05783271
Start Date: 2025-12-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

58

Intervention / Treatment

Gadolinium

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

Study ID: NCT07192952
Start Date: 2026-01-05
End Date: 2030-12-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

117

Intervention / Treatment

Finerenone (Kerendia, BAY94-8862)

Sponsor

Bayer

Source: clinicaltrials.gov

Share:
Add to list

Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea

Study ID: NCT06998095
Start Date: 2025-11-30
End Date: 2029-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment
Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Precision Analgesia for Cardiac Surgery

Study ID: NCT05612399
Start Date: 2026-04-01
End Date: 2026-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment
Sponsor

Kathirvel Subramaniam

Source: clinicaltrials.gov

Share:
Add to list

Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus

Study ID: NCT07149402
Start Date: 2026-08-30
End Date: 2027-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1

Study ID: NCT06373263
Start Date: 2025-12
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

128

Intervention / Treatment

Plain-language summary

Dissemination Tool (Infographic)

Sponsor

Lady Davis Institute

Source: clinicaltrials.gov

Share:
Add to list

Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease

Study ID: NCT06647277
Start Date: 2026-07
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

10

Intervention / Treatment

Fecal Microbiota Transplant

Sponsor

ProgenaBiome

Source: clinicaltrials.gov

Share:
Add to list